University of Toronto is criticised for study of homeopathy in ADHDBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1234 (Published 05 March 2015) Cite this as: BMJ 2015;350:h1234
- Owen Dyer
A study by University of Toronto researchers looking at homeopathic treatment of children and adolescents with attention-deficit/hyperactivity disorder (ADHD) has been criticised in a letter signed by 90 scientists and doctors. They say they are concerned that “the mounting of such a study by a highly reputable researcher at a top notch university will be used by homeopaths to justify diverse aspects of their practice, including steering patients away from evidence-based treatments.”
The trial, which is registered with the US National Institutes of Health,1 is being conducted by a team led by the dean of the Leslie Dan Faculty of Pharmacy, Heather Boon. It is currently recruiting 177 patients aged 6 to 16 years into three double blinded treatment arms: homeopathic consultation and medicine, homeopathic consultation and placebo, and a no treatment group.
The letter originated in the Office for Science and Society of McGill University …